Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Anais Da Academia Brasileira De Ciencias|May 20, 2006
c-Ki-ras oncogene amplification and FGF2 signaling pathways in the mouse Y1 adrenocortical cell lineFábio L Forti, Erico T Costa, Kátia M Rocha, et al.Endocrine Research|January 26, 2005
Molecular mechanisms of cell cycle control in the mouse Y1 adrenal cell lineErico T Costa, Fábio L Forti, Kátia M Rocha, et al.Plos One|November 24, 2011
Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell linesFabricio de Carvalho, Erico T Costa, Anamaria A Camargo, et al.Cancer Research|August 5, 2008
Fibroblast growth factor 2 restrains Ras-driven proliferation of malignant cells by triggering RhoA-mediated senescenceErico T Costa, Fábio L Forti, Tatiana G F Matos, et al.Plos One|September 11, 2014
Fibronectin affects transient MMP2 gene expression through DNA demethylation changes in non-invasive breast cancer cell linesIsabela T Pereira, Edneia A S Ramos, Erico T Costa, et al.Oncotarget|May 24, 2017
High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunityLuis Felipe Campesato, Ana Paula M Silva, Luna Cordeiro, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 26, 2023
Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumorsCamila M L Machado, Magdalena Skubal, Katja Haedicke, et al.Cancer Research|June 25, 2009
ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasisNewton V Verbisck, Erico T Costa, Fabrício F Costa, et al.Chemico-Biological Interactions|September 17, 2021
Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivoAndressa Chequin, Luiz E Costa, Felipe F de Campos, et al.Pageof 1